This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Regulus Therapeutics Inc
RGLS : NASDAQ : Health Care
$6.56 -0.61 | -8.51%
Today's Range: 6.53 - 6.91
Avg. Daily Volume: 94,500
07/10/14 - 4:00 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
RGLS REGULUS THERAPEUTICS INC 8.02 347.72 n/m 17.96 93.45
SNSS SUNESIS PHARMACEUTICALS INC 6.78 408.27 n/m 7.96 38.63
DVAX DYNAVAX TECHNOLOGIES CORP 1.55 407.43 n/m 12.66 34.02
ZIOP ZIOPHARM ONCOLOGY INC 4.00 402.90 n/m 0.80 0.00
GALE GALENA BIOPHARMA INC 3.13 369.42 n/m 4.66 n/a
IMMU IMMUNOMEDICS INC 3.85 356.04 n/m 9.22 101.92
CUR NEURALSTEM INC 3.86 334.90 n/m 0.01 -96.91
SVA SINOVAC BIOTECH LTD 6.01 333.98 37.56 76.02 42.63
RIGL RIGEL PHARMACEUTICALS INC 3.78 330.87 n/m 7.15 376.66
PGNX PROGENICS PHARMACEUTICAL INC 4.67 324.83 n/m 7.45 -46.97
TKMR TEKMIRA PHARMACEUTICALS CORP 13.77 304.00 n/m 17.93 40.72
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

RGLS Ind Avg S&P 500
n/m 58.63 19.71

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs